Aspire BioPharma Valuation
| ASBP Stock | 1.32 0.23 14.84% |
Today, the firm appears to be fairly valued. Aspire BioPharma shows a prevailing Real Value of USD1.27 per share. The current price of the firm is USD1.32. Our model approximates the value of Aspire BioPharma from analyzing the firm fundamentals such as Current Valuation of 13.48 M, return on asset of -1.95, and Shares Owned By Insiders of 10.84 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Aspire BioPharma's price fluctuation is out of control at this time. Calculation of the real value of Aspire BioPharma is based on 3 months time horizon. Increasing Aspire BioPharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Aspire BioPharma's intrinsic value may or may not be the same as its current market price of 1.32, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.32 | Real 1.27 | Hype 1.06 | Naive 1.86 |
The intrinsic value of Aspire BioPharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aspire BioPharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aspire BioPharma helps investors to forecast how Aspire stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aspire BioPharma more accurately as focusing exclusively on Aspire BioPharma's fundamentals will not take into account other important factors: Aspire BioPharma Cash |
|
About Aspire BioPharma Valuation
The stock valuation mechanism determines Aspire BioPharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aspire BioPharma based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aspire BioPharma. We calculate exposure to Aspire BioPharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aspire BioPharma's related companies.Aspire BioPharma Current Valuation Indicators
Aspire BioPharma's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Aspire BioPharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aspire BioPharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aspire BioPharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aspire BioPharma's worth.Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma's price analysis, check to measure Aspire BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma is operating at the current time. Most of Aspire BioPharma's value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma's price. Additionally, you may evaluate how the addition of Aspire BioPharma to your portfolios can decrease your overall portfolio volatility.